VF
KYMR icon

Virtu Financial’s Kymera Therapeutics KYMR Stock Holding History

Virtu Financial’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,283
Closed -$2.12M – 2001
2025
Q4 		$2.12M Buy
+27,283
New +$1.84M 0.08% 151
2025
Q3 		– Sell
-10,362
Closed -$452K – 1802
2025
Q2 		$452K Buy
+10,362
New +$357K 0.02% 609
2024
Q2 		– Sell
-5,147
Closed -$207K – 1617
2024
Q1 		$207K Buy
+5,147
New +$184K 0.02% 773
2021
Q3 		– Sell
-6,085
Closed -$295K – 1743
2021
Q2 		$295K Sell
6,085
-5,773
-49% -$251K 0.03% 734
2021
Q1 		$461K Buy
+11,858
New +$714K 0.03% 559

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Virtu Financial's KYMR Position: Q1 2026 in Review

Virtu Financial sold out of Kymera Therapeutics (KYMR) in Q1 2026, closing a stake of 27,283 shares — an estimated $2.12M sold.

Virtu Financial first reported a position in KYMR in Q1 2021 and held it in 5 quarters. The position peaked at $2.12M in Q4 2025. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Virtu Financial reported no remaining Kymera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 27,283 Kymera Therapeutics shares in Q1 2026, an estimated $2.12M.
  • Virtu Financial first reported a position in Kymera Therapeutics in Q1 2021 and held it in 5 quarters.
  • Virtu Financial's Kymera Therapeutics position peaked at $2.12M in Q4 2025.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.